These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 31875761

  • 1. Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Fossey S, Satapathy SK, Eason JD, Molnar MZ.
    Ren Fail; 2020 Nov; 42(1):40-47. PubMed ID: 31875761
    [Abstract] [Full Text] [Related]

  • 2. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M, Carroll RP, Tsiopelas E, Clayton P, Coates PT.
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [Abstract] [Full Text] [Related]

  • 3. Association between post-transplant donor-specific antibodies and recipient outcomes in simultaneous liver-kidney transplant recipients: single-center, cohort study.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ.
    Transpl Int; 2020 Feb; 33(2):202-215. PubMed ID: 31647143
    [Abstract] [Full Text] [Related]

  • 4. Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Agbim UA, Maliakkal B, Fossey S, Satapathy SK, Sumida K, Kovesdy CP, Nair S, Eason JD, Molnar MZ.
    Nephron; 2020 Feb; 144(3):126-137. PubMed ID: 32007998
    [Abstract] [Full Text] [Related]

  • 5. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
    Das A, Rocque B, Remulla D, Raza M, Barbetta A, Bangerth S, Goldbeck C, Maw TT, Kim J, Kwon Y, Emamaullee J.
    Transplantation; 2023 May 01; 107(5):1115-1123. PubMed ID: 36398988
    [Abstract] [Full Text] [Related]

  • 6. Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies.
    Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.
    Transplantation; 2019 Oct 01; 103(10):2150-2156. PubMed ID: 30720681
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY, Everly MJ, Kaneku H, Banuelos N, Wozniak LJ, Venick RS, Marcus EA, McDiarmid SV, Busuttil RW, Terasaki PI, Farmer DG.
    Transplantation; 2017 Apr 01; 101(4):873-882. PubMed ID: 27490417
    [Abstract] [Full Text] [Related]

  • 8. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 9. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Jul 01; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
    Solomon S, Colovai A, Del Rio M, Hayde N.
    Pediatr Nephrol; 2020 Feb 01; 35(2):261-270. PubMed ID: 31732803
    [Abstract] [Full Text] [Related]

  • 11. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY, Kaneku H, Farmer DG.
    Clin Transpl; 2014 Feb 01; ():153-9. PubMed ID: 26281140
    [Abstract] [Full Text] [Related]

  • 12. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 13. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
    Schluckebier D, Cousin VL, Petit LM, Belli D, Wildhaber B, Rougemont AL, Villard J, Ferrari-Lacraz S, McLin VA.
    Pediatr Transplant; 2020 Feb 27; 24(1):e13611. PubMed ID: 31682057
    [Abstract] [Full Text] [Related]

  • 14. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report.
    Transplantation; 2015 Sep 27; 99(9):1976-80. PubMed ID: 25769065
    [Abstract] [Full Text] [Related]

  • 15. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J.
    Nephrol Dial Transplant; 2016 Oct 27; 31(10):1738-45. PubMed ID: 27220757
    [Abstract] [Full Text] [Related]

  • 16. Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
    O'Leary JG, Gebel HM, Ruiz R, Bray RA, Marr JD, Zhou XJ, Shiller SM, Susskind BM, Kirk AD, Klintmalm GB.
    Am J Transplant; 2013 Apr 27; 13(4):954-960. PubMed ID: 23433356
    [Abstract] [Full Text] [Related]

  • 17. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H, Min JW, Kim JI, Moon IS, Park KH, Yang CW, Chung BH, Oh EJ.
    Medicine (Baltimore); 2016 Mar 27; 95(11):e3094. PubMed ID: 26986147
    [Abstract] [Full Text] [Related]

  • 18. Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.
    Lai C, Newman A, Mawson J, Abou-Daher F, Watson N, Majumdar A, Wyburn K, Chadban S, Gracey D.
    BMC Nephrol; 2020 Feb 12; 21(1):47. PubMed ID: 32050922
    [Abstract] [Full Text] [Related]

  • 19. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Caillard S, Becmeur C, Gautier-Vargas G, Olagne J, Muller C, Cognard N, Perrin P, Braun L, Heibel F, Lefebre F, Renner V, Gachet C, Moulin B, Parissiadis A.
    Transpl Int; 2017 Jan 12; 30(1):29-40. PubMed ID: 27678382
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
    Vandevoorde K, Ducreux S, Bosch A, Guillaud O, Hervieu V, Chambon-Augoyard C, Poinsot D, André P, Scoazec JY, Robinson P, Boillot O, Dubois V, Dumortier J.
    Liver Transpl; 2018 Aug 12; 24(8):1091-1100. PubMed ID: 29665189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.